The Relationship Between the Structure and Toxicity of Aminoglycoside Antibiotics

Overview

Journal Bioorg Med Chem Lett

Specialty Biochemistry

Date 2020 May 4

PMID 32360102

Citations 37

Authors

Moriah Jospe-Kaufman

Liza Siomin

Micha Fridman

Affiliations

Soon will be listed here.

Abstract

Aminoglycoside antibiotics, used to treat persistent gram-negative infections, tuberculosis, and life-threatening infections in neonates and patients with cystic fibrosis, can infer acute kidney injury and irreversible hearing loss. The full repertoire of cellular targets and processes leading to the toxicity of aminoglycosides is not fully resolved, making it challenging to devise rational directions to circumvent their adverse effects. As a result, there has been very limited effort to rationally address the issue of aminoglycoside-induced toxicity. Here we provide an overview of the reported effects of aminoglycosides on cells of the inner ear and on kidney tubular epithelial cells. We describe selected examples for structure-toxicity relationships established by evaluation of both natural and semisynthetic aminoglycosides. The various assays and models used to evaluate these antibiotics and recent progress in development of safer aminoglycoside antibiotics are discussed.

Citing Articles

Synthesis of Methyl Aprabiosaminide and 2-Hydroxyapramycin from Apramycin.

Kasdekar N, Spieker M, Vasella A, Hobbie S, Crich D Org Lett. 2025; 27(8):1918-1922.

PMID: 39950696 PMC: 11877507. DOI: 10.1021/acs.orglett.5c00168.

The Global Challenge of : Antimicrobial Resistance and Emerging Intervention Strategies.

Bukari Z, Emmanuel T, Woodward J, Ferguson R, Ezughara M, Darga N Trop Med Infect Dis. 2025; 10(1).

PMID: 39852676 PMC: 11768457. DOI: 10.3390/tropicalmed10010025.

Synthesis and Antibacterial Activity of New 6″-Modified Tobramycin Derivatives.

Shapovalova K, Zatonsky G, Razumova E, Ipatova D, Lukianov D, Sergiev P Antibiotics (Basel). 2025; 13(12.

PMID: 39766581 PMC: 11672562. DOI: 10.3390/antibiotics13121191.

Protective Effect of Marine Peptide from Against Gentamicin-Induced Hair Cell Damage in Zebrafish.

Zheng H, Zhu R, Zhang Y, Liu K, Xia Q, Li P Mar Drugs. 2024; 22(11).

PMID: 39590799 PMC: 11595687. DOI: 10.3390/md22110519.

Identification of FDA-approved drugs that induce heart regeneration in mammals.

Ahmed M, Nguyen N, Nakada Y, Hsu C, Farag A, Lam N Nat Cardiovasc Res. 2024; 3(3):372-388.

PMID: 39183959 PMC: 11343477. DOI: 10.1038/s44161-024-00450-y.

References

Garneau-Tsodikova S, Labby K . Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives. Medchemcomm. 2016; 7(1):11-27. PMC: 4752126. DOI: 10.1039/C5MD00344J. View

Garreau de Loubresse N, Prokhorova I, Holtkamp W, Rodnina M, Yusupova G, Yusupov M . Structural basis for the inhibition of the eukaryotic ribosome. Nature. 2014; 513(7519):517-22. DOI: 10.1038/nature13737. View

Matsui J, Gale J, Warchol M . Critical signaling events during the aminoglycoside-induced death of sensory hair cells in vitro. J Neurobiol. 2004; 61(2):250-66. DOI: 10.1002/neu.20054. View

Sati G, Shcherbakov D, Hobbie S, Vasella A, Bottger E, Crich D . N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity. ACS Infect Dis. 2017; 3(5):368-377. PMC: 5526222. DOI: 10.1021/acsinfecdis.6b00214. View

Francis S, Katz J, Fanning K, Harris K, Nicholas B, Lacy M . A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity. J Neurosci. 2013; 33(7):3079-93. PMC: 3711767. DOI: 10.1523/JNEUROSCI.3430-12.2013. View

Xie J, Talaska A, Schacht J . New developments in aminoglycoside therapy and ototoxicity. Hear Res. 2011; 281(1-2):28-37. PMC: 3169717. DOI: 10.1016/j.heares.2011.05.008. View

Kalinec G, Fernandez-Zapico M, Urrutia R, Esteban-Cruciani N, Chen S, Kalinec F . Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci U S A. 2005; 102(44):16019-24. PMC: 1276101. DOI: 10.1073/pnas.0508053102. View

BARTZ Q, CONTROULIS J . Dihydrostreptomycin. J Am Chem Soc. 2010; 68(11):2163-6. View

LoBue P . Inhaled tobramycin: not just for cystic fibrosis anymore?. Chest. 2005; 127(4):1098-101. DOI: 10.1378/chest.127.4.1098. View

10.

Ramsey B, Pepe M, Quan J, Otto K, Montgomery A, Borowitz D . Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med. 1999; 340(1):23-30. DOI: 10.1056/NEJM199901073400104. View

11.

Bottger E, Schacht J . The mitochondrion: a perpetrator of acquired hearing loss. Hear Res. 2013; 303:12-9. PMC: 3681877. DOI: 10.1016/j.heares.2013.01.006. View

12.

Davis R . Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103(2):239-52. DOI: 10.1016/s0092-8674(00)00116-1. View

13.

Quirke J, Rajasekaran P, Sarpe V, Sonousi A, Osinnii I, Gysin M . Apralogs: Apramycin 5--Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant. J Am Chem Soc. 2019; 142(1):530-544. PMC: 6949408. DOI: 10.1021/jacs.9b11601. View

14.

Kobayashi M, Sone M, Umemura M, Nabeshima T, Nakashima T, Hellstrom S . Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application. Acta Otolaryngol. 2008; 128(3):245-9. DOI: 10.1080/00016480701558948. View

15.

Takahashi Y, Igarashi M . Destination of aminoglycoside antibiotics in the 'post-antibiotic era'. J Antibiot (Tokyo). 2017; . DOI: 10.1038/ja.2017.117. View

16.

Howard M, Frizzell R, Bedwell D . Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med. 1996; 2(4):467-9. DOI: 10.1038/nm0496-467. View

17.

Kawaguchi H, Naito T, Nakagawa S, Fujisawa K . BB-K 8, a new semisynthetic aminoglycoside antibiotic. J Antibiot (Tokyo). 1972; 25(12):695-708. DOI: 10.7164/antibiotics.25.695. View

18.

Ishikawa M, Garcia-Mateo N, cusak A, Lopez-Hernandez I, Fernandez-Martinez M, Muller M . Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use. Sci Rep. 2019; 9(1):2410. PMC: 6382871. DOI: 10.1038/s41598-019-38634-3. View

19.

Karasawa T, Steyger P . Intracellular mechanisms of aminoglycoside-induced cytotoxicity. Integr Biol (Camb). 2011; 3(9):879-86. PMC: 3662252. DOI: 10.1039/c1ib00034a. View

20.

Matt T, Ng C, Lang K, Sha S, Akbergenov R, Shcherbakov D . Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci U S A. 2012; 109(27):10984-9. PMC: 3390888. DOI: 10.1073/pnas.1204073109. View